[8] Kenny PJ, Markou A. The ups and downs of addiction: role of metabotropic glutamate receptors [J]. TrendsPharmacol Sci, 2004, 25 (5): 265-272.

　　[9] Hui-ling Wang, Yan Zhao, Xiao-hui Xiang, et al. Blockade of ionotropic glutamatergic transmission in theventral tegmental area attenuating the physical signs of morphine withdrawal in rats [J]. ProgNeuro-Psychoph. 2004, 28(7)：1086-1095[10] Mitrano DA, Smith Y. Comparative analysis of the subcellular and subsynaptic localization of mGluR1a andmGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey[J]. J Comp Neurol, 2007; 500(4): 788-806.

　　[11] Palucha A, Branski P, Pilc A. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-inducedmorphine with-drawal symptoms [J]. Pol J Pharmacol, 2004, 56(6): 863-866.

　　[12] Weiss F and Baptista M. mGlu2/3 agonist (LY379268) selectively reverses conditioned reinstatement ofcocaine seeking behavior [J]. Behav. Pharmacol, 2003, 14: S27.

　　[13] Peters J, Kalivas PW. The group II metabotropic glutamate receptor agonist, LY379268, inhibits bothcocaine- and food-seeking behavior in rats [J]. Psychopharmacology, 2006, 186(2): 143-149.

　　[14] Markou A. The role of metabotropic glutamate receptors in drug reward, motivation and dependence [J].Drug News Perspect, 2007, 20 (2): 103-108.

　　[15] Zhu H, Barr GA. The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infantrats [J]. Int J Dev Neurosci, 2004, 22(5-6): 379-95.

　　[16] Gabra BH, Afify EA, Daabees TT, et al. The role of the NO/NMDA pathways in the development ofmorphine withdrawal induced by naloxone in vitro [J]. Pharmacol Res, 2005, 51(4): 319-327.

　　[17] Wang JQ, Fibuch EE, Mao L. Regulation of mitogen-activated protein kinases by glutamate receptors [J]. J Neurochem, 2007, 100: 1-11.

　　[18] Lapish CC, Seamans JK, Chandler LJ. Glutamate-dopamine cotransmission and reward processing inaddiction [J]. Alcohol. Clin. Exp. Res., 2006, 30(9): 1451-1465.

　　[19] Guan JS, Xu ZZ, Gao H, et al. Interaction with vesicle luminal protachykinin regulates surface expression ofdelta-opioid receptors and opioid analgesia [J]. Cell, 2005,122(4):619-31.

　　[20] Qi Zhang, Yan Zhao, Yuan Guo, et al. Electrophysiological evidence for the interaction of substance P andglutamate on Aδ and C afferent fibre activity in rat hairy skin [J]. Clin Exp Pharmacol P, 2006, 33:1128–1133.

　　[21] L. Xu, Y. Zhao, S.-Q. Zhan, et al. Temporal and Spatial Expression of Preprotachykinin A Messenger RNAin the Developing Filial Mice Brain after Maternal Administration of Monosodium Glutamate at a Late Stageof Pregnancy [J]. Neuroscience, 2007, 145, 974-980.